Benchmark maintained a 'Buy' rating and $32 price target for IMAX on August 29, 2025.
2 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benchmark maintained a 'Buy' rating and $32 price target for IMAX on August 29, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
IMAX
large-screen film format
Nothing else this week.
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
Related events
- CoreCivic received a buy rating and boosted price objective from Benchmark, while MarketBeat published consensus rating data.
- Benchmark reaffirmed a buy rating on Spire Global, while MarketBeat provided consensus rating data for the company.
- Benchmark downgraded its shares from buy to hold, while Morgan Stanley and Citigroup issued rating updates.
- Benchmark restated a buy rating on Rambus shares.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- StockStoryWhy IMAX (IMAX) Stock Is Up Today Shares of premium cinema technology company IMAX (NYSE:IMAX) jumped 0.2% in the morning session after Benchmark maintained its 'Buy' rating and a $32 price target on